Semaglutide for Weight Loss: What the SURMOUNT-5 Results Mean for Northwest Louisiana Patients For the first time, a major clinical trial put tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) head to head in people with obesity who do not have diabetes, and the results landed in the New England Journal of Medicine in May 2025.[1] The short answer: tirzepatide produced significantly more weight loss
If you are interested in Semaglutide GLP-1 injections at Flawless MedSpa, the first step is to schedule a consultation with Melanie Speed, APRN, NP-C, CANS
It belongs to a novel class of drugs known as triple agonists, meaning it simultaneously activates three hormone receptors: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor
Use a hard-sided cooler with ice packs and keep it in the shade
"I was sluggish, tired, and had no energy," she said
Renukuntla J, Vadlapudi AD, Patel A, Boddu SH, Mitra AK